Investment Rating - The report indicates a strong growth potential for the micro-ecological skincare industry, with a projected market size increase from 26.33 billion RMB in 2019 to 83.65 billion RMB in 2024, and further growth to 190.66 billion RMB by 2029, reflecting a compound annual growth rate (CAGR) of 16.51% from 2025 to 2029 [5][33]. Core Insights - The micro-ecological skincare industry utilizes probiotics and other functional ingredients to regulate skin flora and maintain skin micro-ecological balance, driven by increasing consumer awareness of skin health and natural skincare concepts [5][36]. - The industry is characterized by significant technological barriers, high cross-industry dependencies, and strong consumer demand, with a notable shift towards health-oriented skincare products [11][12][14]. - The report highlights the rapid growth of the micro-ecological skincare market, with a projected CAGR of 26% for the segment, significantly outpacing the overall cosmetics industry growth [21][32]. Summary by Sections Industry Definition - Skincare products aim to improve skin quality and address specific skin issues, with micro-ecological skincare products focusing on maintaining skin micro-ecological balance through the use of probiotics and prebiotics [6]. Industry Characteristics - **Technological Barriers**: The development of micro-ecological skincare products requires advanced biological and cosmetic engineering technologies, with strict control over microbial species and quantities [11]. - **Cross-Industry Dependencies**: The industry relies heavily on interdisciplinary research and technological support from microbiology, dermatology, and immunology [13]. - **Consumer Demand**: There is a growing consumer interest in health-oriented natural skincare, with increasing awareness of skin micro-ecology concepts on social media [14]. Development History - The micro-ecological skincare field in China began gaining attention around 2010, with significant advancements in research and product development occurring post-2018 [15][17][18]. Industry Chain Analysis - The industry chain consists of upstream suppliers of microbial materials and packaging, midstream brand manufacturers, and downstream consumers [19]. - Recent breakthroughs in domestic probiotic strains have led to reduced costs in the midstream sector, enhancing product differentiation [20][27]. Market Size and Growth - The market size of the micro-ecological skincare industry is expected to grow from 26.33 billion RMB in 2019 to 83.65 billion RMB in 2024, with a CAGR of 26.01% [33]. - Factors driving this growth include increased consumer focus on skin health and the rising demand from aging and male demographics [36][38]. Competitive Landscape - The competitive landscape features leading brands such as 瑷尔博士 (Aier Doctor), 理肤泉 (La Roche-Posay), and 湖畔实验室 (Lake Lab), with a focus on technological innovation and product efficacy [42][43]. - The report notes that both foreign and domestic brands are intensifying their efforts in the micro-ecological skincare market, leading to a more fragmented competitive environment [45].

Core Viewpoint - The international beauty industry, particularly for Beiersdorf, is facing significant challenges including conservative consumer behavior in Europe and the US, intensified competition in China, and fluctuations in high-end skincare demand. The traditional growth model of "big products + global distribution" is becoming ineffective, necessitating a reassessment of brand portfolio quality and growth stability [3]. Group 1: Performance Overview - Beiersdorf's performance trajectory over the past five years can be divided into two phases: from 2021 to 2023, the company achieved rapid growth through strong brands and market expansion, culminating in record performance in 2023. In 2024, despite global skincare market pressures, the company still achieved approximately 6.5% organic growth [4]. - In 2025, the global skincare market growth is expected to slow further to about 1.5% to 2%. However, Beiersdorf's results reflect a repositioning of growth quality rather than merely a decline in growth rate, with a sales figure of €9.9 billion and an organic growth of 2.4% [4][12]. Group 2: Brand Performance - The flagship brand Nivea maintained its scale but experienced a slight growth slowdown, with 2025 sales increasing by 0.9% to €5.5 billion. The CEO expressed higher expectations for Nivea, which is undergoing a critical adjustment phase aimed at balancing innovation and market depth [7][17]. - The Derma segment, driven by brands like Eucerin and Aquaphor, achieved sales of €1.5 billion in 2025, marking an 11.7% growth and demonstrating stable growth over five consecutive years [8]. - The high-end brand La Prairie faced market volatility, with organic sales declining by 4.5% to €478 million. However, there was a marginal improvement in the fourth quarter, indicating potential for long-term value [11]. Group 3: Strategic Adjustments - Beiersdorf's strategy in China for 2025 focuses on "deepening" and "investing," emphasizing localized operations and the introduction of key active ingredients like Thiamidol, which has completed its localization process [14][16]. - Nivea's strategic adjustment in China aims to shift focus from price-sensitive personal care to high-end skincare, utilizing digital channels for accelerated growth. This includes streamlining product offerings and optimizing distribution processes [17][19]. - Eucerin's brand in China also launched successful new products and marketing initiatives, resulting in a 29.35% increase in e-commerce sales in 2025 [21][23]. Group 4: Innovation and Research - Beiersdorf's sustained performance can be attributed to its long-term commitment to foundational scientific research and innovative technologies. The company has focused on three high-value research areas: pigmentation mechanisms, anti-aging solutions, and skin microbiome science [28][29]. - The company has developed a groundbreaking technology utilizing skin-derived probiotics aimed at treating acne-prone skin, with plans to launch a new product line in 2026 [29][30]. Group 5: Future Outlook - Despite a challenging market environment in 2026, Beiersdorf anticipates stable or slightly organic growth in net sales, with a focus on leveraging its strong brand matrix and deep skincare expertise [30].

Core Insights - The article highlights a significant breakthrough in the field of microecological skincare with the launch of the "IdealSkin Match" data platform by the brand Aier Doctor, in collaboration with Professor Su Xiaoqian's team from Qingdao University, utilizing AI technology and research on ideal skin microbiomes [1][6]. Group 1: Ideal Skin Concept - The "Ideal Skin" concept is defined through a comprehensive understanding of skin microbiomes and physiological parameters, marking a shift from traditional skincare practices to a more scientific approach [2][10]. - Aier Doctor is the first skincare brand in China to establish a database for the ideal skin microbiome, aiming to create a healthy skin state for the Chinese population [10][19]. Group 2: Data Platform and AI Model - The "IdealSkin Match" platform integrates over 9.6 million high-quality facial microbiome gene sequences and more than 19,000 skin physiological parameters, enabling a multidimensional analysis of skin health [10][11]. - The platform employs machine learning algorithms, specifically XGBoost, to enhance the accuracy of skin health assessments, transitioning from experience-based to data-driven skincare management [11][12]. Group 3: Innovation and Research - Aier Doctor has invested in foundational research on skin microbiomes, establishing two databases to explore the correlation between skin microbiomes and physiological parameters [15][16]. - The company has developed innovative products, such as the "287 Barrier Bacteria" technology, which targets the growth of skin barrier bacteria and enhances skin protection [17][18]. Group 4: Industry Impact - The launch of the "IdealSkin Match" platform signifies a milestone in the innovation of microecological skincare products in China, promoting a shift towards intelligent skincare solutions [10][19]. - Aier Doctor's commitment to scientific research and product development positions it as a leader in the Chinese skin microecology industry, contributing to the advancement of skincare technology [19].

Core Insights - The recent technology appraisal meeting organized by Shandong Light Industry Association recognized two significant scientific achievements from Furuida Biopharmaceuticals, marking them as "internationally leading" and "internationally advanced" in the fields of functional skin microbiome and zinc hyaluronate research [1][7]. Group 1: Research Achievements - The project on "Preparation of Zinc Hyaluronate and Its Application in Skincare Products" has successfully overcome technical bottlenecks over a five-year research period, establishing the first domestic detection standard and demonstrating effective targeting of 5α-reductase [3]. - The project has resulted in the publication of 2 scientific papers and the granting of 3 invention patents, filling a research gap in the precise oil control and soothing skincare direction for zinc hyaluronate derivatives [3]. Group 2: Functional Skin Microbiome Research - The project "Research on Functional Skin Microbiome and Development of Functional Care Products" has created a correlation database linking skin microbiome distribution to physiological parameters across different populations, establishing a functional skin microbiome screening platform [5]. - This project has led to the application for 10 invention patents, with 4 granted, and the publication of 7 scientific papers, including 5 in SCI journals, thereby setting a standard in the field of microbiome science in skincare [5]. Group 3: Future Directions - Furuida Biopharmaceuticals aims to continue its deep exploration in the fields of zinc hyaluronate and skin microbiome, establishing itself as a benchmark in the hyaluronate industry and leading the scientific skincare sector [9].